Photo pending

No product photo yet: we only show official photos, with the manufacturer’s permission.

Lifeward · Wearables & Exos

Lifeward ReWalk 7

Available to order · Prescription

CE marked since September 2025 and supplied in Germany by Lifeward GmbH (Berlin), usually paid by statutory health insurers; users need medical screening and training first.

Price on request

No public list price; normally reimbursed. For reference, the US Medicare lump-sum payment rate set in April 2024 is US$91,032 (US$81,929–109,238 depending on the state). In Germany, Lifeward has supply contracts with several statutory insurers, including BARMER.

Request via Antarum

Checked: 28.09.2026Source
Made for: Home
Where: Germany (Lifeward GmbH, via insurers) · EU (CE marked) · US

Antarum is independent: we don’t sell or ship robots and aren’t an official dealer of this brand. You buy from the manufacturer or an authorised dealer. They’re your contract partner.

Manufacturer price in the original currency, excl. VAT, shipping and import duties.

How Antarum earns money

Overview

A personal powered exoskeleton that lets people with spinal cord injury stand, walk, and climb stairs and curbs at home and outdoors, using crutches. Version 7 adds push-button crutch control, customisable walking speeds and cloud connectivity.

Key specs

Use: Standing and walking on level ground, mild slopes, stairs and curbs
Controls: Push buttons on the crutch · smartwatch · MyReWalk app
Walking speeds: Two customisable speeds
Connectivity: Cloud connection, therapist handheld for training
US indication: Spinal cord injury T7–L5 at home; T4–T6 in rehab centres
Approvals: FDA (March 2025) · CE mark (September 2025)

Why it’s in

The personal exoskeleton for everyday life: made for use at home and in the city, including stairs and curbs.
A real route in Europe: CE marked, a Berlin subsidiary, and insurer contracts covering about 45% of people with statutory health insurance in Germany.
Seventh generation of a system with a long track record, now with app, smartwatch and cloud support.

What bothers us

Lifeward is small and loss-making (about US$9.4 million cash in June 2026); long-term service is a real question.
Only for suitable users after medical screening and training, and walking still needs crutches.
Weight, battery life and size limits of version 7 are not published.